Showing results (441-450 of 489) with videos related to

Sort By:
Pageof 49
The Journal of Investigative Dermatology|April 9, 2010
Deletion of Late Cornified Envelope 3B and 3C genes is not associated with atopic dermatitisJudith G M Bergboer, Patrick L J M Zeeuwen, Alan D Irvine, et al.
American Journal of Human Genetics|May 26, 2009
Copy-number mutations on chromosome 17q24.2-q24.3 in congenital generalized hypertrichosis terminalis with or without gingival hyperplasiaMiao Sun, Ning Li, Wu Dong, et al.
JAAD International|November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
Skin Health and Disease|June 30, 2025
A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocolElizaveta Gribaleva, Niels Steen Krogh, David Prieto-Merino, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2011
Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergySara J Brown, Yuka Asai, Heather J Cordell, et al.
The British Journal of Dermatology|July 24, 2024
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR registerHelen Alexander, Rayka Malek, David Prieto-Merino, et al.
Nature Genetics|August 27, 2013
Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wastingLiat Samuelov, Ofer Sarig, Robert M Harmon, et al.
The Journal of Investigative Dermatology|August 14, 2016
Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) MutationsJulie Soblet, Jaakko Kangas, Marjut Nätynki, et al.
The Journal of Allergy and Clinical Immunology|September 9, 2008
Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema riskStephan Weidinger, Hansjörg Baurecht, Stefan Wagenpfeil, et al.
The British Journal of Dermatology|September 18, 2023
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trialCarsten Flohr, Anna Rosala-Hallas, Ashley P Jones, et al.
Pageof 49